Quest Products Recalls ALOCANE Emergency Burn Pads Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning

What was recalled

The U.S. Consumer Product Safety Commission has issued a recall for the ALOCANE® Emergency Burn Pads, a common over-the-counter pain relieving product manufactured by Quest Products. This recall is not limited to a single variation of the item but specifically targets two package sizes: the 10-count boxes and the 15-count boxes of these gel-infused pads. If you have recently purchased burn treatment supplies from a pharmacy, grocery store, or online retailer, it is important to verify whether your specific box falls into this affected group.

To identify if you possess the recalled product, look closely at the packaging. The affected boxes are white and red in color and feature the text "MAXIMUM STRENGTH ALOCANE® Emergency Burn Pads" printed clearly on the front. Inside each box are gel-infused pads containing lidocaine at a concentration of 4%, which serves as the active ingredient to numb pain from minor burns and scalds. While the product itself is designed for safe relief, the issue lies in the container's design rather than the medicinal content.

You can confirm if your box is part of this recall by checking two specific identifiers printed on the packaging. First, look at the bottom of the box for the Universal Product Code (UPC). The recalled items all share the UPC number 8-46241-02448-7. Second, check the side of the box near the barcode for the lot number. Only boxes with one of the following lot numbers are included in this recall: 4179, 4180, 4235, 4645, 4646, or 4698. If your box has a different lot number or UPC, it is not part of this specific safety notice.

Although the official recall announcement from November 14, 2019, does not specify the exact retail locations or dates of sale for these units, the product was widely distributed as a standard consumer good. Because the hazard involves the packaging failing to meet federal child-resistant closure requirements, any box matching the descriptions above should be treated with caution until properly handled. The recall aims to ensure that families have access to safe alternatives that do not pose an accidental ingestion risk to young children.

The hazard, explained

At first glance, a box of emergency burn pads might seem like a standard household staple, tucked away in a medicine cabinet or under the sink for quick access during kitchen mishaps. However, the core issue with this specific recall is not the product’s effectiveness in treating burns, but rather its packaging design. The ALOCANE® Emergency Burn Pads were distributed in containers that failed to meet the strict child-resistant closure standards mandated by the Poison Prevention Packaging Act (PPPA). This federal law was established decades ago specifically to address a critical vulnerability in consumer safety: young children are naturally curious and lack the cognitive development to understand the dangers of ingesting foreign substances. Their fingers are small, dexterous, and strong enough to manipulate simple latches or caps that adults find difficult to open. When packaging does not require a specific combination of force and coordination—such as pushing down while twisting—that most two- to five-year-olds cannot achieve, the barrier between the child and the hazardous material effectively disappears.

The danger lies in what is inside the box. These pads are gel-infused with lidocaine, a local anesthetic that works by blocking nerve signals in the body to prevent pain sensations. While lidocaine is safe and effective for topical use on adult skin when applied correctly, it becomes toxic if ingested or absorbed in significant quantities through the mouth. If a child gains access to these pads due to the inadequate closure, they may place one in their mouth out of curiosity or to soothe teething gums. Because the pad is saturated with the medication, even a small amount of absorption through the oral mucosa can lead to systemic poisoning. This is not merely a minor upset stomach; it is a serious medical event.

Lidocaine toxicity can manifest rapidly in children because their bodies process drugs differently than adults. Their smaller body mass means that a dose considered therapeutic for an adult can be overwhelming for a toddler. Symptoms of poisoning may include dizziness, confusion, blurred vision, nausea, vomiting, and in severe cases, seizures or irregular heart rhythms. The risk is compounded by the fact that children often do not exhibit obvious distress immediately after ingestion, leading to delays in seeking medical attention. This recall highlights a common but dangerous oversight in product design: assuming that a parent’s vigilance is sufficient when the packaging itself should serve as the first line of defense. By failing to incorporate child-resistant mechanisms, the manufacturer inadvertently turned a tool for healing into a potential hazard for the most vulnerable members of the household.

It is important to understand that this is not an isolated incident in the history of consumer products. Regulatory agencies frequently recall items because packaging evolves, manufacturing processes change, or new safety data emerges. The Poison Prevention Packaging Act requires that certain household substances be packaged in containers that are significantly difficult for children under five years of age to open, while remaining reasonably easy for adults to use. When a product like the ALOCANE® pads fails this test, it creates a gap in safety that relies entirely on adult supervision rather than engineered prevention. Since no accidents have been reported to date, we do not know exactly how many children may have come into contact with these products, but the potential for harm remains real and immediate until the package is secured or returned.

Who is most at risk

While the immediate trigger for this recall is a packaging defect rather than a flaw in the medication itself, the potential consequences create a specific and serious vulnerability profile. The primary group at risk consists of young children, particularly those under the age of five. This demographic is not just incidentally exposed but is actively targeted by the product's location in the home. Emergency burn pads are typically stored in kitchens, bathrooms, or first-aid cabinets—areas that are accessible to curious toddlers who explore their environment by putting objects in their mouths. The hazard here is not merely that a child might find the box, but that the box’s design fails to prevent them from opening it. Because the packaging does not meet the stringent Child Resistant Closure Requirement mandated by the Poison Prevention Packaging Act, a determined child can easily remove the pads without adult assistance.

The specific danger lies in the active ingredient: lidocaine, which is present at a 4% concentration in these ALOCANE® Emergency Burn Pads. Lidocaine is a local anesthetic that works by blocking nerve signals. While safe and effective for temporary pain relief when used correctly by adults, it becomes toxic if ingested improperly. Young children have smaller body masses and developing metabolic systems, meaning they require significantly less of a substance to experience adverse effects compared to adults. If a child places one or more of these gel-infused pads in their mouth, they are not just tasting a topical medication; they are ingesting a concentrated dose of anesthetic directly into their digestive system.

The risk of poisoning for children is multifaceted. Once ingested, lidocaine can be absorbed rapidly through the gastrointestinal tract. For a small child, this can lead to symptoms ranging from dizziness and nausea to more severe central nervous system effects, such as seizures or respiratory depression. Because the recall notes that no incidents have been reported yet, it is crucial to understand that the danger is latent but real. The lack of current reports does not indicate safety; it indicates that the failure has not yet resulted in a documented emergency. However, the potential for harm is high because the product is designed to be moist and gel-infused, which may make it appealing or easy to swallow for a child who is mouthing objects. Furthermore, parents and caregivers might assume the packaging is secure simply because it is a commercial product, leading to a false sense of security. This recall serves as a critical reminder that standard retail packaging is not always sufficient protection against determined toddlers, especially when the contents are potent medications.

Adults using the product are generally at lower risk regarding poisoning, provided they follow usage instructions. However, they bear the responsibility of storage and supervision. If an adult mistakenly believes the box is child-resistant due to its professional appearance, they may leave it within reach, inadvertently creating the very hazard the recall aims to prevent. Therefore, everyone who owns this product is part of the risk equation, but young children remain the most vulnerable population due to their physical accessibility to the product and their physiological sensitivity to lidocaine toxicity.

How to tell if you have the recalled item

If you have a box of ALOCANE® Emergency Burn Pads sitting in your medicine cabinet or first-aid kit, it is important to verify whether yours is part of this specific recall before taking any action. The good news is that identifying the affected products is straightforward because Quest Products has provided very clear, visual markers on the packaging. You do not need to open the box or inspect the individual pads to determine if they are included in this safety notice; everything you need to know is printed directly on the exterior of the container.

First, look at the front of the box. The recalled items are specifically labeled as "MAXIMUM STRENGTH ALOCANE® Emergency Burn Pads." The packaging for these products features a distinct white and red color scheme. Be aware that this recall applies to two specific package sizes: the 10-count box and the 15-count box. If your box does not clearly state one of these two quantities, or if the branding looks different, it is likely not part of this particular issue. However, if you see the white and red box with that specific maximum strength labeling, you must proceed to check the internal details.

The most critical step in identification is checking the lot numbers, as not all ALOCANE pads are affected—only those manufactured during specific production runs. Turn the box over and look next to the barcode on the side or bottom panel. You need to find a series of digits labeled as the lot number. The recall affects only the following six lot numbers: 4179, 4180, 4235, 4645, 4646, and 4698. If your box has any other lot number, it is safe from this specific recall notice. It is a good idea to write down the lot number before you proceed with the return process, as customer service representatives will need to verify this information.

For even greater certainty, you can also verify the Universal Product Code (UPC). The recalled products carry the UPC number 8-46241-02448-7. This code is typically located on the bottom of the box. While the lot number is the primary identifier for the specific defective batches, having the correct UPC confirms that you are holding the exact product model subject to this safety alert. If your package matches the visual description (white and red box, maximum strength labeling) and contains one of the six listed lot numbers, it is part of the recall. In that case, please stop using the pads immediately and follow the remedy steps outlined in the next section to ensure your family’s safety.

What to do — step by step

Your refund, repair, or replacement options

If you have determined that you possess one of the recalled ALOCANE® Emergency Burn Pads, the good news is that Quest Products has established a straightforward and generous remedy to make things right. Because the issue stems from packaging safety rather than a defect in the product’s ability to treat burns, the company is not asking you to simply throw the pads away without recourse. Instead, they are offering two distinct paths for resolution: a full refund of your purchase price or a replacement with a safer version of their product. This approach ensures that you are not left out of pocket for a safety recall, nor are you left without a solution for minor burn care if you still need it.

The first option available to you is a complete refund. If you prefer not to keep any related products from Quest Products, or if you simply want your money back, you are entitled to receive a full reimbursement. This means that every dollar you spent on the affected 10-count or 15-count boxes of pads will be returned to you. To initiate this process, you must contact Quest Products directly. They have set up a dedicated customer service line for this recall, which you can reach at 800-650-0113. It is important to note that their support team is available from 9 a.m. to 5 p.m. Central Time, Monday through Friday. If you prefer written communication or need to send digital documentation of your purchase, you can also visit their official website at www.alocane.com and navigate to the “Contact Us” section to submit your request online.

The second option is a replacement that addresses the specific safety flaw identified in this recall. Quest Products will send you a free ALOCANE® Emergency Burn Gel in a 2.5-ounce tube that features child-resistant closure packaging. This is a significant upgrade in terms of safety compliance, as it meets the requirements of the Poison Prevention Packaging Act, thereby eliminating the risk of accidental poisoning by young children. This replacement product is offered at no cost to you, including any shipping or handling fees associated with sending the new item to your home. This option is particularly useful if you found the burn pads effective for minor injuries and wish to continue using the ALOCANE brand, but now with peace of mind regarding child safety.

To take advantage of either the refund or the free replacement tube, you will need to return the original recalled pads. The recall instructions specify that you should contact Quest Products to arrange for the return of the pain-relieving pads. While the specific mailing address is not detailed in the summary of facts provided, the company has made it clear that they are handling the logistics of this return process. You do not need to pay for shipping to send the recalled items back to them. Once you have reached out via phone or their online contact form, a representative will guide you through the next steps, which will likely involve providing your lot number (from the list of affected numbers: 4179, 4180, 4235, 4645, 4646, or 4698) and your proof of purchase. This verification step ensures that you are within the scope of the recall and eligible for the remedy.

It is worth emphasizing that this process is designed to be as frictionless as possible. The goal of the CPSC and Quest Products is to remove the hazardous packaging from homes while ensuring that consumers who relied on this product are compensated or provided with a safe alternative. There are no complicated forms to fill out independently, nor are there strict deadlines mentioned in the immediate facts other than the urgency to stop using the product now. By taking the time to call or click through to their website, you not only secure your financial interest but also contribute to public safety by ensuring these non-compliant packages do not remain in circulation.

What can happen if you ignore it

When a recall is issued for a product that sits in your medicine cabinet or bathroom drawer, the immediate instinct is often to shrug it off, especially if the item seems harmless or if you haven’t personally experienced any trouble. However, ignoring this specific recall regarding the ALOCANE Emergency Burn Pads carries tangible and potentially serious health risks that extend far beyond a simple packaging defect. The core issue here is not that the pads don’t work—they are designed to provide maximum strength relief for burns—but rather that their container fails to meet federal safety standards designed to protect the most vulnerable among us.

The primary danger lies in the interaction between the product’s active ingredient and young children. These pads contain lidocaine, a local anesthetic that numbs the skin to relieve pain. While lidocaine is safe for adults when used as directed on their own uninjured skin, it becomes highly toxic if ingested by a small child. Because the packaging does not meet the Child Resistant Closure requirements mandated by the Poison Prevention Packaging Act, a curious toddler or young child can easily open the box and access the gel-infused pads. If a child places one of these pads in their mouth, they are not just tasting a medicinal substance; they are ingesting a concentrated dose of a drug that their small body cannot process safely.

The consequences of such ingestion can range from mild distress to severe medical emergencies. Lidocaine poisoning in children can manifest in several ways, including drowsiness, vomiting, and difficulty breathing. In more severe cases, it can lead to seizures, heart rhythm abnormalities, or even coma. There is no way for a parent to know in advance how much lidocaine might be absorbed through the mucous membranes of a child’s mouth or stomach lining, making every instance of potential access a roll of the dice with a child’s health. Although the CPSC notes that no incidents have been reported to date, this absence of reported cases is not an indication of safety; it is simply a lack of data on what *could* happen if the hazard materializes.

Ignoring the recall also means leaving a preventable hazard in your home for an indefinite period. The recalled lots (4179, 4180, 4235, 4645, 4646, and 4698) are still potent and capable of causing harm long after the November 2019 recall date. By continuing to keep these items in an accessible location, you are essentially leaving a trap for any child who can reach them. The risk is not theoretical; it is a direct result of engineering a product with a non-compliant closure system while containing a substance that requires strict containment. Choosing to ignore the remedy offered by Quest Products means choosing to gamble with the safety of your household, relying on luck rather than a guaranteed solution to prevent accidental poisoning.

Staying safe: broader tips

While this specific recall addresses a packaging failure for a topical burn treatment, the underlying issue is universal: how we store household chemicals and medications determines their safety profile. The Poison Prevention Packaging Act exists to create a barrier between potent substances and curious hands, but that barrier only works if we respect it. For every item in your home that contains active ingredients—whether it is lidocaine for burns, ibuprofen for pain, or antifungal creams for skin conditions—treat the packaging as part of the safety system, not just a container. If a box arrives looking damaged, or if you notice that a cap does not click shut with the resistance described in the instructions, do not assume it is just a manufacturing quirk. That failure can be the difference between a harmless accident and a medical emergency.

One of the most effective strategies for preventing accidental poisoning is to stop relying on "high shelves" as your primary defense. Young children are remarkably agile climbers and have an innate curiosity about anything shiny or colorful, which often includes medicine bottles and boxes. Instead, utilize locked cabinets or dedicated storage units that require a key or a complex combination. This physical separation removes the element of opportunity entirely. Even if a child can reach a high cabinet, they cannot open a lock. Furthermore, consider the "one-and-done" rule: never transfer medications or medical supplies into generic food containers or unlabeled jars. Clear labeling and original packaging provide immediate visual cues about what the substance is and its potency, which is critical for first responders if an incident does occur.

It is also vital to stay proactive regarding product safety updates. Regulatory agencies like the Consumer Product Safety Commission (CPSC) issue recalls not just for defective products, but for items that pose a hidden risk even when used correctly. You can subscribe to email alerts from the CPSC or check their website regularly. When you buy new health supplies, take a moment to register them if possible, or simply note the lot numbers in your phone. This habit ensures that if a recall is announced later, you can quickly determine if your specific batch is affected without digging through cluttered medicine cabinets.

Finally, educate all household members, including older children and caregivers, on the basic rules of chemical safety. Teach them that any substance not meant to be eaten must be kept away from the mouth and face. Reinforce that "medicine" is not a candy substitute and that any spill or broken seal should be reported to an adult immediately. By combining secure storage with open communication and vigilance against packaging defects, you create a robust safety net that protects your family long after the immediate recall news has passed.